Www.highpoint.edu

Dosage adjustments were made to achieve physiological and therapeutic T3 levels along with symptom relief. The mean follow-up duration was 27 months (range 1–111 months). The average dose of DTE was 30 mg, and for this population, the average TSH remained normal in 96.5% of patients (P < 0.05), and T4 remained normal in 96.5% of patients (P=1). ................
................